Core Scientific, Inc.
CORZ- Exchange
- Nasdaq
- Industry
- Finance Services
- SEC CIK
- 0001839341
In the last 90 days, Core Scientific, Inc. insiders filed 3 open-market purchases and 12 sales; 415 institutions reported holding it in 13F filings for Q2 2026, worth $9.35B in total; 4 superinvestors hold it, including Oaktree Capital and Tiger Global Management.
Key figures
- Market capClose on Nov 9, 2026
- $4.10B
- Insider buysLast 90 days, $342.3K in total
- 3
- Insider sellsLast 90 days, $1.96M in total
- 12
- 13F holdersQ2 2026, +29 vs. previous quarter
- 415
- 13F valueReported value at the end of Q2 2026
- $9.35B
- Superinvestors holdingAt the end of Q2 2026
- 4
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $319.0M
- −37.5% year over year
- Net income, FY2025
- -$288.6M
- No comparable prior period
- Free cash flow, FY2025
- -$450.8M
- No comparable prior period
- Revenue, Q3 FY2026
- $232.9M
- +187.1% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $288.6M (90.5% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 76.6M
- Shares sold short
- Change
- +10.6M
- +16.1% vs. previous
- Days to cover
- 5.16
- At average daily volume
Superinvestors holding CORZ, Q2 2026
Go to the superinvestors tab4 superinvestors report holding Core Scientific, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Oaktree Capital
Howard Marks
2.4%
Core Scientific, Inc.'s share of the portfolio
- Shares
- 4,993,708
- Value
- $127.8M
Tiger Global Management
Chase Coleman
0.1%
Core Scientific, Inc.'s share of the portfolio
- Shares
- 817,000
- Value
- $20.9M
| Superinvestor | Weight | Value |
|---|---|---|
| Third Point | <0.1% | $1.38M |
| Soros Fund Management | <0.1% | $899.4K |
Latest insider trades
See all insider tradesOpen-market purchases and sales by Core Scientific, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2026 (view filing)4:21 PM ET | Nov 2 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $12.78 | −$127.8K | −0.9%1.12M after | 2 lots10b5-1 |
| Oct 28, 2026 (view filing)4:18 PM ET | Oct 26 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $13.56 | −$135.6K | −0.9%1.13M after | 2 lots10b5-1 |
| Oct 20, 2026 (view filing)4:05 PM ET | Oct 19 | 1 day | Duchene Todd MSee remarks | SSale | −10.0K | $13.87 | −$138.7K | −0.9%1.14M after | 10b5-1 |
| Oct 14, 2026 (view filing)4:07 PM ET | Oct 12 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $15.12 | −$151.2K | −0.9%1.16M after | 10b5-1 |
| Oct 7, 2026 (view filing)4:50 PM ET | Oct 5 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $16.31 | −$163.1K | −0.8%1.17M after | 10b5-1 |
| Sep 30, 2026 (view filing)4:40 PM ET | Sep 28 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $16.76 | −$167.6K | −0.8%1.19M after | 10b5-1 |
| Sep 23, 2026 (view filing)4:11 PM ET | Sep 21 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $18.37 | −$183.7K | −0.8%1.20M after | 10b5-1 |
| Sep 17, 2026 (view filing)4:26 PM ET | Sep 15 | 2 days | Weiss Eric StantonDirector | PPurchase | +6.00K | $16.33 | +$98.0K | +2.3%265.3K after | |
| Sep 16, 2026 (view filing)4:01 PM ET | Sep 14 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $17.14 | −$171.4K | −0.8%1.21M after | 10b5-1 |
| Sep 10, 2026 (view filing)4:08 PM ET | Sep 8 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $18.67 | −$186.7K | −0.8%1.22M after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 415 holdersThe largest institutional positions in Core Scientific, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 28,122,262 | $719.6M | 0.01% | +3,492,391+14.2% | Added |
| Situational Awareness LP | 26,008,473 | $665.6M | 3.30% | 00.0% | Unchanged |
| Jericho Capital Asset Management L.P. | 22,882,942 | $585.6M | 4.84% | +11,159,492+95.2% | Added |
| Vanguard Portfolio Management LLC | 18,661,783 | $477.6M | 0.02% | +47,247+0.3% | Added |
| UBS Group AG | 15,889,496 | $406.6M | 0.06% | −9,644,444−37.8% | Reduced |
| Vanguard Capital Management LLC | 13,797,507 | $353.1M | 0.01% | +432,618+3.2% | Added |
| Two Sigma Investments, LP | 10,275,907 | $263.0M | 0.20% | +4,689,937+84.0% | Added |
| Geode Capital Management, LLC | 8,495,597 | $244.6M | 0.01% | +691,916+8.9% | Added |
| Value Aligned Research Advisors, LLC | 9,187,797 | $235.1M | 1.41% | +1,468,835+19.0% | Added |
| Two Seas Capital LP | 9,028,509 | $231.0M | 8.82% | −7,123,324−44.1% | Reduced |
Holders of 5% or more of CORZ
See all 7 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Core Scientific, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.80%23.3M shares | – | Oct 24, 20243 filings | Jul 16, 2025 | SEC |
| MFN Partners, LP | 13G | 7.60%24.5M shares | New | Oct 28, 20261 filing | Oct 28, 2026 | SEC |
| Jericho Capital Asset Management L.P. | 13G | 7.20%22.9M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Citadel Securities GP LLC | 13G | 6.50%20.9M shares | +2.40 ppfrom 4.10% | Dec 10, 20253 filings | Aug 5, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G | 5.97%18.8M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |